R & D

NordicRWE develops R&D-based solutions that support drug development by utilizing the unique Nordic health data infrastructure. We have a scientific mindset and a research-driven approach, and collaborate with data holders, clinical experts and partners from academia. Our ambitious goal is to position Nordic health data in the forefront of data-driven drug R&D and regulatory decision-making.

Our ongoing R&D projects

RWE Accelerate

NordicRWE is supported by a major public research grant from the Research Council of Norway for the period October 2021 to December 2025 (grant no. 327887).

Biobank Norway

NordicRWE has entered into a collaboration with the national research infrastructure for human biobanks in Norway, Biobank Norway (bbmri.no) to do molecular profiling on archived tumor tissue samples in hospital biobanks.

Customer research collaboration

NordicRWE has several ongoing customer RWE research collaborations with internationally recognized biopharma companies. We are a full-service provider committed to handling customer research projects, all the way from initial study concept discussions to final reporting. We work within all therapeutic areas and support the entire RWE value chain wherever there is a need for real-world evidence to drive customer value creation.

RWE customer case study examples

External control arm and clinical trial contextualization of a neoantigen-based therapeutic cancer vaccine for an international biotech company

Disease epidemiology, treatment patterns and real-world outcomes for common chronic disease for a Nordic pharma affiliate

Target trial emulation study in the field of oncology to support access and launch for a global pharma company

Curious to learn more about NordicRWE?

Send e-mail

Steinar Thoresen

MD, Ph.D. Medical Director